Skip to content

Comparison of the Effects of Different-Sided Stellate Ganglion Block on Healthy Subjects Based on Real-Time Heart Rate Variability: A Prospective, Randomized, Crossover Trial

Comparison of the Effects of Different-Sided Stellate Ganglion Block on Healthy Subjects Based on Real-Time Heart Rate Variability: A Prospective, Randomized, Crossover Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114678
Enrollment
Unknown
Registered
2025-12-16
Start date
2025-12-17
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Group A:Unilateral stellate ganglion block guided by ultrasound:The subject remains in a supine position with the head slightly extended. After skin disinfection, the puncture site and direction are l
Group B:Unilateral stellate ganglion block guided by ultrasound:The subject remains in a supine position with the head slightly extended. After skin disinfection, the puncture site and direction are l

Sponsors

Longgang District People's Hospital of Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18–60 years; (2) Body mass index (BMI) < 28 kg/m^²; (3) Willing to provide voluntary written informed consent.

Exclusion criteria

Exclusion criteria: (1) Presence of sleep disorders within the last 3 months; (2) Ectopic heartbeats >= 5 times per minute, or any form of arrhythmia with a non-1:1 P/R ratio; (3) Coagulation dysfunction; (4) Diagnosis of malignant tumors, or severe cardiovascular/cerebrovascular diseases, hepatic/renal diseases, hematologic disorders, or psychiatric illnesses; (5) Experiencing severe infection, recent surgery, or other acute stress states within the past month, or being in an acute or unstable phase of any disease; (6) Pregnancy or lactation; (7) Local skin infection at the SGB injection site; (8) Extensive skin burns, ulceration, inflammatory reactions, severe desquamation in the precordial area, or severe thoracic deformity; (9) Use of psychotropic drugs, ß-blockers, or other medications affecting HRV; (10) Any other condition considered by the investigator to be unsuitable for the trial or that may interfere with the completion of required assessments.

Design outcomes

Primary

MeasureTime frame
Heart rate variability;

Secondary

MeasureTime frame
Sleep quality;

Countries

China

Contacts

Public ContactHongxin Ji

Longgang District People's Hospital of Shenzhen

hongxinji@163.com+86 28 932 833 8186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026